Inhalation Sciences Sweden AB (publ) (XSAT:ISAB)

XSAT:ISAB Revenue

Inhalation Sciences Sweden AB had revenue of 2.70M SEK in the quarter ending June 30, 2026, with 246.85% growth. This brings the company's revenue in the last twelve months to 8.30M, up 54.96% year-over-year. In the year 2025, Inhalation Sciences Sweden AB had annual revenue of 3.04M, down -72.47%.

• Revenue (ttm): 8.30M
• Revenue Growth: +54.96%
• P/S Ratio: 0.88
• Revenue / Employee: 1.66M
• Employees: 5
• Market Cap: 7.30M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.04M	-8.01M	-72.47%
Dec 31, 2024	11.05M	-6.46M	-36.89%
Dec 31, 2023	17.50M	5.31M	43.55%
Dec 31, 2022	12.19M	2.77M	29.42%
Dec 31, 2021	9.42M	-715.00K	-7.05%
Dec 31, 2020	10.14M	1.19M	13.28%
Dec 31, 2019	8.95M	3.51M	64.47%
Dec 31, 2018	5.44M	-2.58M	-32.17%
Dec 31, 2017	8.02M	806.00K	11.17%
Dec 31, 2016	7.22M	-	-

Data Source: Fiscal.ai Last updated: Aug 24, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 27, 2026

Data Sources Report a data error